Integrative network toxicology and pharmacology reveal that kaempferol alleviates BaP-triggered pulmonary fibrosis via suppressing Ras/COX-2-dependent cellular senescence
Open Access
- 15 October 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1963570
Abstract
Background: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease. Benzo[a]pyrene (BaP), a major constituent of cigarette smoke and air pollution, has been closely associated with pulmonary fibrosis. However, its molecular mechanism remains unclear. The natural flavonoid kaempferol possesses anti-inflammatory and antioxidant properties. However, its effects and mechanisms in BaP-induced pulmonary fibrosis remain unclear. Objectives: This study aimed to predict potential targets of BaP-induced fibrosis and kaempferol intervention in BaP-induced IPF, and to validate whether kaempferol reverses BaP-induced epithelial senescence and fibrosis via the Ras/COX-2 signaling pathway in vitro . Methods: Network toxicology, network pharmacology, machine learning, and molecular docking were integrated to predict potential targets of BaP-induced fibrosis and kaempferol intervention, followed by GO and KEGG pathway enrichment analyses. Additionally, virtual knockout analysis was performed to explore the regulatory relationships among Ras, COX-2, and cellular senescence. MLE-12 cells were used as an in vitro model, and senescence-related indicators were assessed by SA-β-gal staining, Western blot, and ELISA. Results: KEGG enrichment analysis revealed that these targets were significantly enriched in the Ras signaling pathway. Molecular docking confirmed that kaempferol exhibited good binding affinity for the above target proteins. Cell experiments demonstrated that BaP significantly promoted cellular senescence and activated Ras and COX-2. Kaempferol treatment effectively reversed these changes. Conclusion: This study reveals that BaP promotes IPF by inducing epithelial cell senescence via the Ras/COX-2 signaling pathway. Kaempferol may exert anti-fibrotic effects by counteracting this pathway-mediated senescence. These findings provide a theoretical basis for the pulmonary fibrosis effects of BaP and support kaempferol as a potential anti-fibrotic agent.Keywords
This publication has 34 references indexed in Scilit:
- Six1 promotes alveolar epithelium senescence in pulmonary fibrosis through regulating Tp53International Immunopharmacology, 2025
- Kaempferol inhibits atherosclerotic plaque development via dual-targeting of p53-p21-p16 senescence pathway and Nrf2/HO-1/NQO1 antioxidant mechanism: Insights from combined in vivo and in vitro researchInternational Immunopharmacology, 2025
- The Role of p53‐Mediated Cellular Senescence in Idiopathic Pulmonary FibrosisComprehensive Physiology, 2025
- Kaempferol: Unveiling its anti-inflammatory properties for therapeutic innovationCytokine, 2025
- Benzo[a]pyrene evokes epithelial-mesenchymal transition and pulmonary fibrosis through AhR-mediated Nrf2-p62 signalingJournal of Hazardous Materials, 2024
- Benzo(a)pyrene in Europe: Ambient air concentrations, population exposure and health effectsEnvironmental Pollution, 2016
- Polycyclic aromatic hydrocarbons and their quinones modulate the metabolic profile and induce DNA damage in human alveolar and bronchiolar cellsInternational Journal of Hygiene and Environmental Health, 2013
- Cellular senescence involves an intracrine prostaglandin E2 pathway in human fibroblastsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2013
- The effect of occupational exposure to benzo[a]pyrene on neurobehavioral function in coke oven workersAmerican Journal of Industrial Medicine, 2012
- Sulfur dioxide and benzo(a)pyrene modulates CYP1A and tumor‐related gene expression in rat liverEnvironmental Toxicology, 2009